ARTL
Artelo Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.91
−4.98%Aug 20, 2026, 12:52 UTC
Artelo Biosciences announced that the Japanese Patent Office issued a notice of allowance and Decision to Grant for its patent application covering the intended commercial formulation of ART27.13.
Source:Aug 17, 2026, 12:52 UTC
Artelo Biosciences announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for a patent application covering the intended commercial formulation of ART27.13, expected to extend patent protection through 2041.
Source: